2-chlorodeoxyadenosine (2-CDA) for the t
โ
Stine, Kimo C.; Saylors, Robert L.; Williams, Laura L.; Becton, David L.
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 192 KB
๐ 2 views
Background. Pediatric patients with Langerhans cell histiocytosis (LCH) may become refractory to conventional therapy or present with repeated recurrences over several years. Current therapeutic options such as prednisone, vinblastine, etoposide, and cyclosporine are associated with significant acut